Skip to main content

Smith & Nephew Plc Value Stock - Dividend - Research Selection

Smith + Nephew Plc

ISIN: GB0009223206, WKN: 502816

Market price date: 25.01.2022
Market price: 16,26 USD


Smith + Nephew Plc Fundamental data and company key figures of the share

Annual reports in USD
Key figures 15-06-2021
Cash flow
Net operating cash flow 935.000.000
Capital Expenditures -443.000.000
Free cash flow 492.000.000
Balance sheet
Total Equity 5.279.000.000
Liabilities & Shareholders equity 11.012.000.000
Income statement
Net income 448.000.000
Eps (diluted) 0,512
Diluted shares outstanding 875.000.000
Net sales/revenue 4.560.000.000

Fundamental ratios calculated on: 25-01-2022

Ratios
Key figures 25-01-2022
Cash flow
P/C 15,22
   
P/FC 28,92
Balance sheet
ROI4,07
ROE47,94
Income statement
P/E31,76
Div. Yield2,34%
P/B2,70
P/S3,12


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolSNNUF
Market Capitalization14.227.500.032,00 USD
CountryUnited Kingdom
IndicesFTSE 100,STOXX EUROPE 600,MSCI World Index
SectorsHealth Care Equipment
Raw Data SourceIFRS in Millionen USD
Stock Split
Internetwww.smith-nephew.com


Description of the company

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.smith-nephew.com


NEWS


Vertex Pharmaceuticals (VRTX) Q4 2021 Earnings Call Transcript

2022-01-27
Image source: The Motley Fool.

Flex (FLEX) Q3 2022 Earnings Call Transcript

2022-01-27
Image source: The Motley Fool.

Aspen Technology, Inc. (AZPN) Q2 2022 Earnings Call Transcript

2022-01-27
Image source: The Motley Fool.

Iron ore creeps higher on China demand hopes, supply fears

2022-01-27
Dalian iron ore prices rose on Thursday on hopes of robust demand for the steelmaking ingredient in China when steel production curbs are eased after next month's Beijing Winter Olympics.

Liveperson Inc Shares Fall 1.4% Below Previous 52-Week Low - Market Mover

2022-01-27
Liveperson Inc (LPSN) shares closed 1.4% lower than its previous 52 week low, giving the company a market cap of $2B. The stock is currently down 20.4% year-to-date, down 56.7% over the past 12 months, and up 257.7% over the p

Toast Inc - Class A Shares Fall 1.3% Below Previous 52-Week Low - Market Mover

2022-01-27
Toast Inc - Class A (TOST) shares closed 1.3% lower than its previous 52 week low, giving the company a market cap of $1B. The stock is currently down 38.9% year-to-date, down 66.1% over the past 12 months, and down 66.1% over

Stellantis to raise stake in China JV with GAC to 75%

2022-01-27
Carmaker Stellantis plans to increase its stake in its joint venture with Guangzhou Automobile Group (GAC) in China to 75% from 50% to set new grounds for business in the Asian market, it said in a statement on Thursday.

STMicro to double annual investments to meet high chip demand

2022-01-27
French-Italian chipmaker STMicroelectronics said on Thursday it planned to double its investments in 2022 from a year ago to up to $3.6 billion, buoyed by high demand that drove its earnings to beat expectations in the fourth quarter.

Now or never? European banks eye comeback against Wall Street

2022-01-27
Replenished firepower and higher interest rates will give Europe's banks an ideal opportunity this year to reverse recent underperformance and claw back market share from rivals in the United States, industry experts say.

Taiwan battery maker ProLogium signs investment deal with Mercedes-Benz

2022-01-27
Taiwanese battery maker ProLogium Technology Co on Thursday said it has signed a cooperation agreement with Daimler AG's Mercedes-Benz to build test vehicles equipped with co-developed solid-state batteries in the coming years.